Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Michael A. Tidwell"'
Autor:
Amy M. Schuster, Jenna A. Van Fossen, Shubham Agrawal, Sicheng Wang, Elizabeth A. Mack, Michael L. Tidwell, Shelia R. Cotten
Publikováno v:
Transportation Research Interdisciplinary Perspectives, Vol 26, Iss , Pp 101164- (2024)
Automated vehicle (AV) adoption is anticipated to affect millions of motor vehicle operators, including gig drivers (platform-based ride-hailing and/or delivery drivers). The multidisciplinary body of research investigating worker attitudes towards a
Externí odkaz:
https://doaj.org/article/ca2c7b6bb07046328bcfaea7c16646f3
Autor:
Shubham Agrawal, Amy M. Schuster, Noah Britt, Elizabeth A. Mack, Michael L. Tidwell, Shelia R. Cotten
Publikováno v:
Technology in Society. 72:102186
Autor:
Michael L. Tidwell, Maria R. Baer, Mya S. Thein, Nora Oliver, Edward A. Sausville, Farin Kamangar, Briana Short, Vu H. Duong, Ashkan Emadi
Publikováno v:
Leukemia & Lymphoma. 56:2082-2086
Patients with acute leukemia develop venous thrombosis (VT) related to central venous catheters (CVCs). Anticoagulation (AC) in these patients who are thrombocytopenic and often coagulopathic is challenging. To evaluate the safety and efficacy of AC
Autor:
Emily J. Vannorsdall, Dan P. Zandberg, Bhavana Bhatnagar, Vu H. Duong, Qing Chen, Maria R. Baer, Michael L. Tidwell
Publikováno v:
Leukemia & Lymphoma. 56:1718-1722
The hypomethylating agents azacitidine and decitabine are standard therapy for myelodysplastic syndromes (MDS), and are often used to treat patients with acute myeloid leukemia (AML) unlikely to benefit from cytotoxic chemotherapy. Switching hypometh
Autor:
Michael L. Tidwell, Ching Chen, Maria R. Baer, Yi Ning, Ashkan Emadi, Feyruz V. Rassool, Theodore Stewart Gourdin, Vu H. Duong, Ying Zou
Publikováno v:
Cancer Genet
FLT3 internal tandem duplication (ITD) mutations are present in acute myeloid leukemia (AML) in 30% of patients with acute myeloid leukemia (AML), most commonly in those with a normal karyotype, and are associated with short relapse-free survival. Bo
Autor:
Tony E. Reeves, Jonathan Bohmann, William E. Bauta, Donald M. Maxwell, Bismarck Campos, Michael W. Tidwell, Stanton F. McHardy, Michael R. Corbett, Richard E. Sweeney, Ambrosio Lopez, William R. Cantrell, John McDonough, Karen M. Brecht, Christopher J. Bemben, Tony A. Menchaca, Paul M. Thompson
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:1711-1714
The goal of this research was to identify structurally novel, non-quaternarypyridinium reactivators of GF (cyclosarin)-inhibited hAChE that possess the capacity to mediate in vitro reactivation of GF-inhibited human acetylcholinesterase (hAChE). New
Autor:
Theodore Stewart Gourdin, Michael L. Tidwell, Vu H. Duong, Ashkan Emadi, Ching Chen, Maria R. Baer, Edward A. Sausville, Bhavana Bhatnagar, Yi Ning
Publikováno v:
Leukemia & Lymphoma. 55:1533-1537
We retrospectively reviewed outcomes in 45 previously untreated patients with acute myeloid leukemia (AML) considered unfit for chemotherapy who were treated with 10-day courses of decitabine 20 mg/m(2) daily outside of a clinical trial, with no cut-
Autor:
Christopher A. Iobst, Stephen Swirsky, Michael A. Tidwell, Avi C. Baitner, Craig Spurdle, Wesley F King
Publikováno v:
Journal of Children's Orthopaedics
Background The management of pediatric type I open fractures remains controversial. There has been no consistent protocol established in the literature for the non-operative management of these injuries. Methods A protocol was developed at our instit
Autor:
Anthony D. Sung, Michael W. Evans, Maria R. Baer, Ivana Gojo, Judith E. Karp, Mark J. Levis, Michael L. Tidwell, Jacqueline Greer
Publikováno v:
Leukemia & Lymphoma. 53:660-664
CD4 count ≤200×10(6) cells/L has been identified as a predictor of short survival in HIV-associated acute myeloid leukemia (HIV-AML), but karyotype, which is the best predictor of survival in AML, has not been evaluated in HIV-AML patients. A retr
Autor:
Michael W. Tidwell, Norbert Klugbauer, Andrey A. Kolokoltsov, Christian Wahl-Schott, William E. Bauta, Yasuteru Sakurai, Cheng-Chang Chen, Christian Grimm, Martin Biel, Robert A. Davey
Publikováno v:
Science (New York, N.Y.). 347(6225)
Channeling Ebola virus entry into the cell The current outbreak of Ebola virus in West Africa highlights the need for antiviral therapies. One strategy would be to block the Ebola virus's ability to enter host cells. Cells engulf Ebola virus particle